Meet Our Authors
- PDF / 498,895 Bytes
- 3 Pages / 585 x 783 pts Page_size
- 87 Downloads / 203 Views
i Biomedical Research Institute, Korea Institute of Science and Technology, South Korea; email [email protected]. Choi is currently the head of the Biomedical Research Institute at the Korea Institute of Science and Technology. He received a PhD degree from the Department of Bioengineering at the University of Michigan in 1991. He has served as the president of the Korean Society of Biomechanics and as the chief editor of the Journal of Biomedical Engineering Research. His current research interests include bioengineering, rehabilitation engineering, and development of nano-biomaterials, including theranostic nanoparticles.
Seungpyo Hong Department of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, IL, USA; tel. 312-413-8294; and email [email protected]. Hong is an assistant professor in the Department of Biopharmaceutical Sciences at the University of Illinois at Chicago. He graduated from Hanyang University in Seoul, Korea, with BS and MS degrees in polymer engineering in 1999 and 2001, respectively. In 2006, he received a PhD degree from the University of Michigan. Hong then joined the Massachusetts Institute of Technology as a postdoc in Robert Langer’s laboratory. Since 2008, he has led a research group at UIC with a major research theme of “Biomimetic Nanotechnology.” He has published over 45 peer-reviewed articles, 4 book chapters, and has 10 issued or pending patents. Hao-Jui Hsu University of Illinois at Chicago, IL, USA; email [email protected]. Hsu received a MS degree in pharmaceutical sciences from the National Taiwan University in 2007, and then worked for Orient Pharma Co., Ltd., before he joined the Department of Biopharmaceutical Sciences in 2011. He is currently a PhD candidate in Seungpyo Hong’s group. His research currently focuses on the development of dendron-based micelles for targeted cancer therapy. He has co-authored five peer-reviewed articles since 2007. Namho Kim Korea Institute of Science and Technology, South Korea; email [email protected]. Kim is currently a research scientist at the Korea Institute of Science and Technology. He lived in the United States for 12 years, and he returned to Seoul upon receiving a MS degree in 2010 at Purdue University. He also has a BS degree in bioengineering from Lehigh University. His current main research focus is in siRNA delivery methods and novel biomaterials.
Ick Chan Kwon Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, South Korea; tel. +82 2 958 5912; and email [email protected]. Kwon is a principal research scientist at the Center for Theragnosis at the Korea Institute of Science and Technology. He received a PhD degree in pharmaceutics and pharmaceutical chemistry from the University of Utah in 1993. He serves as the president of the Korean Society of Molecular Imaging, as an Asian editor of the Journal of Controlled Release, and as a member of several editorial boards. His current research interests include targeted drug delivery with polymeric nanoparticles and the d
Data Loading...
